BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma

Watanabe, J., Clutter, M. R., Gullette, M. J., Sasaki, T., Uchida, E., Kaur, S., Mo, Y., Abe, K., Ishi, Y., Takata, N., Natsumeda, M., Gadd, S., Zhang, Z., Becher, O. J., & Hashizume, R. (2024). BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma. Journal of Clinical Investigation, 134(13). https://doi.org/10.1172/jci174794
Authors:
Jun Watanabe
Matthew R. Clutter
Michael J. Gullette
Takahiro Sasaki
Eita Uchida
Savneet Kaur
Yan Mo
Kouki Abe
Yukitomo Ishi
Nozomu Takata
Manabu Natsumeda
Samantha Gadd
Zhiguo Zhang
Oren J. Becher
Rintaro Hashizume
Affiliated Authors:
Yan Mo
Zhiguo Zhang
Columbia Affiliation:
Subjects:
Radiation Tolerance (MeSH)
Histones (MeSH)
Targeted Protein Degradation in Biomedical Research (OpenAlex Topic)
Chromatin Remodeling in Cancer and Development (OpenAlex Topic)
Gliomas (OpenAlex Topic)
Author Keywords:
brain cancer
epigenetics
oncology
therapeutics
translation
elink
Publication Type:
Article
Unique ID:
10.1172/jci174794
PMID:
38771655
DOI:
10.1172/jci174794
Journal:
Journal of Clinical Investigation
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: